Ramírez SMLP, López PGT, Varela RMA

Language: Spanish
References: 35
Page: 118-122
PDF size: 183.40 Kb.

ABSTRACT

Antibiotics are the drugs most prescribed by doctors, they modify the microbiota throughout the body, especially at the intestinal level, causing changes in immune, endocrinological and metabolic functioning. Antibiotics cause a temporary and sometimes permanent impact on health, generating high rates of resistance, considering that the damage is greater if they are used early in life.

REFERENCES

1. Dreser, A., “Uso de antibióticos en México: revisión de problemas y políticas”, Salud Pública Méx, 2008, 50 (Supl 4): s480-487.

2. Vázquez Tsuji, O. y Campos Rivera, T., “Regulación de la venta de antibióticos”, Epidemiología, 2010, 4: 47.

3. Macho Aizpurúa, M., Antimicrobianos y microbiota, Bilbao, Servicio de Microbiología Clínica y Control de la infección, Hospital Universitario de Basurto.

4. Morgan, D., et al., “Non-prescription antimicrobial use worldwide: a systematic review”, Lancet Infect Dis, 2011, 11: 692-701.

5. European Centre for Disease Prevention and Control, Surveillance of antimicrobial consumption in Europe 2012, Estocolmo, ecdc, 2014.

6. González Saldaña, N y Saltigeral Simental, P., Guía de antimicrobianos, antivirales, antiparasitarios, antimicóticos e inmunomoduladores, 9ª ed., México, 2011.

7. Gerardo, T., López Pérez, D., Mendoza Hernández, A. y Rodríguez González, M., Alergia y sus comorbilidades, 1a ed., México, 2018, pp. 16-21.

8. Dethlefsen, L. y Relman, D., “Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation”, Proc Nat Aca Sci, 2010, 108 (Suppl 1): 4554-4561.

9. Jernberg, C. et al., “Long-term impacts of antibiotic exposure on the human intestinal microbiota”, Microbiology, 2010, 56: 3216-3223.

10. Icaza-Chávez, M.E., “Microbiota intestinal en la salud y la enfermedad”, Rev Gastroenterología Mex, 2013, 78 (4): 240-248.

11. Vangay, P., Ward, T., Gerber, J.S. y Knights, D., “Antibiotics, pediatric dysbiosis and disease”, Cell Host Microbe, 2015, 17 (5): 553-564.

12. Becattini, S., Taur, Y. y Pamer, E.G., “Induced changes in the intestinal microbiota and the disease”, Trends Mol Med, 2016, 22: 458-478.

13. Cox, L., et al., “Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences”, Cell, 2014, 158: 705-721.

14. O’Sullivan, O. et al., “Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy”, J Antimicrob Chemother, 2012, 68: 214-221.

15. Castañeda Guillot, C., “Microbiota intestinal e inmunidad intestinal”, Rev Gastrohnup, 2016, 18 (3): e44-e48.

16. Willing, B. et al., “Shifting the balance: antibiotic effects on host-microbiota mutualism”, Nat Rev Microbiol, 2011, 9: 233-243.

17. Vangay, P., Ward, T., Gerber, J.S. y Knights, D., “Antibiotics, pediatric dysbiosis and disease”, Cell Host Microbe, 2015, 17 (5): 553-564.

18. Jakobsson, H., et al., “Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome”, plos One, 2010, 5 (3): e9836.

19. Mikkelsen, K. et al., “Effect of antibiotics on gut microbiota, gut hormones and glucose metabolism”, plos One, 2015, 10: e0142352.

20. Ottman, N. et al., “The function of our microbiota: who is out there and what do they do?”, Front Cell Inf Microbiol, 2012, 2: 104.

21. Kociolek, L. y Gerding, D., “Breakthroughs in the treatment and prevention of Clostridium difficile infection”, Nat Rev Gastroenterol Hepatol, 2016, 13: 150-160.

22. Rupnik, M. et al., “Clostridium difficile infection: new developments in epidemiology and pathogenesis”, Nat Rev Microbiol, 2009, 7: 526-536.

23. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Domínguez- Bello, M.G., Contreras M. et al., “Human gut microbiome viewed across age and geography”, Nature, 2012, 486: 222-227.

24. Francino, M.P., “Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances”, Front Microbiol, 2016, 6: 1543.

25. Bach, J., “The effect of infections on susceptibility to autoimmune and allergic diseases”, N Engl J Med, 2002, 347: 911-920.

26. Becattini, S. et al., “Antibiotic-induced changes in the intestinal microbiota and disease”, Trendsi Mol Med, 2016, 22: 458-478.

27. Michel Aceves, R.J., Izeta Gutiérrez, A.C. y Torres Alarcón, G., “La microbiota y el microbioma intestinal humano”, Rev Sanid Milit Mex, 2017, 71 (5): 443-448.

28. Willing, B. et al., “Shifting the balance: antibiotic effects on host-microbiota mutualism”, Nat Rev Microbiol, 2011, 9: 233-243.

29. Sullivan, A. et al., “Effect of antimicrobial agents on the ecological balance of human microflora”, Lancet Infect Dis, 2001, 1: 101-114.

30. Arboleya, S. et al., “Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics”, J Pediatr, 2015, 166: 538-544.

31. Boursi, B. et al., “The effect of past antibiotic exposure on diabetes risk”, Gastroenterol, 2015, 148: s-84.

32. Russell, S. et al., “Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma”, embo Reports, 2012, 13: 440-447.

33. Lapin, B. et al., “Relationship between prenatal antibiotic use and asthma in at-risk children”, Ann Allergy Asthma Immunol, 2015, 114: 203-207.

34. Matthew, P. et al., “Antibiotic exposure and ibd development among children: a population-based cohort study”, Pediatrics, 2012, 130: e794-e803

35. Arvonen, M. et al., “Gut microbiota-host interactions and juvenile idiopathic arthritis”, Pediatr Rheumatol, 2016, 14: 55.